These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29406692)

  • 21. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
    Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
    Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
    Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.
    Delang L; Li C; Tas A; Quérat G; Albulescu IC; De Burghgraeve T; Guerrero NA; Gigante A; Piorkowski G; Decroly E; Jochmans D; Canard B; Snijder EJ; Pérez-Pérez MJ; van Hemert MJ; Coutard B; Leyssen P; Neyts J
    Sci Rep; 2016 Aug; 6():31819. PubMed ID: 27545976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity of silymarin against chikungunya virus.
    Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
    Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms.
    Ho YJ; Liu FC; Yeh CT; Yang CM; Lin CC; Lin TY; Hsieh PS; Hu MK; Gong Z; Lu JW
    Antiviral Res; 2018 Nov; 159():134-142. PubMed ID: 30300716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
    Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of chikungunya virus replication.
    Scuotto M; Abdelnabi R; Collarile S; Schiraldi C; Delang L; Massa A; Ferla S; Brancale A; Leyssen P; Neyts J; Filosa R
    Bioorg Med Chem; 2017 Jan; 25(1):327-337. PubMed ID: 27856239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral Activity of Diterpene Esters on Chikungunya Virus and HIV Replication.
    Nothias-Scaglia LF; Pannecouque C; Renucci F; Delang L; Neyts J; Roussi F; Costa J; Leyssen P; Litaudon M; Paolini J
    J Nat Prod; 2015 Jun; 78(6):1277-83. PubMed ID: 25970561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
    Pohjala L; Utt A; Varjak M; Lulla A; Merits A; Ahola T; Tammela P
    PLoS One; 2011; 6(12):e28923. PubMed ID: 22205980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses.
    Ching KC; Kam YW; Merits A; Ng LF; Chai CL
    J Med Chem; 2015 Dec; 58(23):9196-213. PubMed ID: 26540338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jatrophane diterpenes as inhibitors of chikungunya virus replication: structure-activity relationship and discovery of a potent lead.
    Nothias-Scaglia LF; Retailleau P; Paolini J; Pannecouque C; Neyts J; Dumontet V; Roussi F; Leyssen P; Costa J; Litaudon M
    J Nat Prod; 2014 Jun; 77(6):1505-12. PubMed ID: 24926807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond Members of the
    Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
    Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
    Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bis(benzofuran-thiazolidinone)s and bis(benzofuran-thiazinanone)s as inhibiting agents for chikungunya virus.
    Hwu JR; Gupta NK; Tsay SC; Huang WC; Albulescu IC; Kovacikova K; van Hemert MJ
    Antiviral Res; 2017 Oct; 146():96-101. PubMed ID: 28830714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library.
    Cruz DJ; Bonotto RM; Gomes RG; da Silva CT; Taniguchi JB; No JH; Lombardot B; Schwartz O; Hansen MA; Freitas-Junior LH
    PLoS Negl Trop Dis; 2013; 7(10):e2471. PubMed ID: 24205414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of a peptide-fusion protein (Latarcin-PAP1-Thanatin) against chikungunya virus.
    Rothan HA; Bahrani H; Shankar EM; Rahman NA; Yusof R
    Antiviral Res; 2014 Aug; 108():173-80. PubMed ID: 24929084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.